Table 2 The significant subpathways identified by Subpathway-CorSP using prostate cancer data set (Pā<ā0.05).
Subpathway ID | PathwayName | Subpathway-CorSP | Pathway-G | Pathway-M | IMPaLA | Subpathway-GM | Possible relation to the cancer | Reference (PMID) |
|---|---|---|---|---|---|---|---|---|
path:00260_1 | Glycine, serine and threonine metabolism | 0.00024269 | 0.52409080 | 0.16216414 | 0.08498874 | 0.00017964 | De novo Purine synthesis | 19063642; 15229480 |
path:00563_1# | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 0.00096023 | 0.39629916 | 1 | 1 | 1 | Suppress invasion of prostate and breast cancer cells | 16822939 |
path:00510_4# | N-Glycan biosynthesis | 0.00137850 | 0.11717815 | 1 | 1 | 1 | Efficient detection of prostate cancer | 18701493; 25154914 |
path:00562_1 | Inositol phosphate metabolism | 0.00339828 | 0.19556203 | 0.44168527 | 0.08637687 | 0.00760810 | Membrane receptor signaling cascades and anti-cancer activity | 14608114; 20414202 |
path:00340_1 | Histidine metabolism | 0.00396946 | 0.47151833 | 0.13647964 | 0.06435265 | 0.00289440 | Cell proliferation | 16203768; 18347416 |
path:00910_1 | Nitrogen metabolism | 0.00434048 | 0.72281060 | 0.0552906 | 0.03996463 | 0.01352617 | Enhance anti-cancer activity | 23746196; 26174441 |
path:00561_1# | Glycerolipid metabolism | 0.00464301 | 0.93511527 | 0.38902790 | 0.36378593 | 0.29439641 | High energy demand and cell propagation | 18757836; 21802006 |
path:00601_1 | Glycosphingolipid biosynthesis - lacto and neolacto series | 0.00573235 | 0.16469429 | 1 | 1 | 0.02863259 | Cell adhesion and the growth of tumor cells | 20428086; 19658179 |
path:00052_1 | Galactose metabolism | 0.00657521 | 0.16469429 | 0.02167594 | 0.00356990 | 1 | Toxic to ovarian cells | 25586565; 21335998 |
path:00010_1 | Glycolysis/Gluconeogenesis | 0.00947690 | 0.46000521 | 0.37041772 | 0.17039408 | 0.00059735 | Energy demand of colorectal cancer tissues | 19678709; 19063642 |
path:00030_1 | Pentose phosphate pathway | 0.00962547 | 0.05589567 | 0.01106147 | 0.00061828 | 0.00040717 | Increase cytotoxicity and oxidative stress | 25560241; 24861463 |
path:00270_2# | Cysteine and methionine metabolism | 0.01530709 | 0.12895515 | 1 | 1 | 1 | Prostate cancer cell invasion and aggressivity | 20718469; 21853037 |
path:00620_1 | Pyruvate metabolism | 0.01530709 | 0.64619119 | 1 | 1 | 0.04290499 | Maintain of colon cancer cells | 20919825; 18789002 |
path:00360_1# | Phenylalanine metabolism | 0.02129967 | 1 | 0.23763160 | 1 | 1 | High metabolic rate in cancer | 20919825; 18789002 |
path:00330_1 | Arginine and proline metabolism | 0.02749154 | 0.95093432 | 0.00182141 | 0.00173204 | 2.96E-05 | Colon cancer inhibition and tumoral energy production | 20919825; 19678709 |
path:00983_4# | Drug metabolism-other enzymes | 0.02828285 | 0.78112433 | 1 | 1 | 1 | Metabolism of anti-cancer drug | 21215737; 21533940 |
path:00450_1# | Selenoamino acid metabolism | 0.02872727 | 0.16469429 | 1 | 1 | 0.07222314 | As inhibitors of histonedeacetylase in human prostate cancer cells | 19584079; 15041072 |
path:00670_1# | One carbon pool by folate | 0.02897254 | 0.25510731 | 1 | 1 | 1 | Ā | ā |
path:00770_1 | Pantothenate and CoA biosynthesis | 0.03578242 | 0.21421764 | 0.00686790 | 0.00147122 | 1 | Ā | ā |
path:00480_1 | Glutathione metabolism | 0.04742966 | 0.93864190 | 0.01768909 | 0.01660372 | 0.00389595 | Impact resistance of cancer cells | 26056813; 25144624 |